Inventor · disambiguated record
David C. Dalgarno
Also filed as: DALGARNO DAVID C
25 granted patents·29 pending applications·281 citations·filing 2000–2025
96Inventor score
Top patents by PatentIndex Score
54 records- 0195US8114874B2Substituted acetylenic imidazo[1,2-B]pyridazine compounds as kinase inhibitorsZOU Dong·Filed 2006·Granted Feb 14, 2012·53 cites·55 claims
- 0294US9273077B2Phosphorus derivatives as kinase inhibitorsARIAD PHARMA INC·Filed 2013·Granted Mar 1, 2016·13 cites·51 claims
- 0393US9029533B2Substituted acetylenic imidazo[1,2-A]pyridazines as kinase inhibitorsARIAD PHARMA INC·Filed 2013·Granted May 12, 2015·14 cites·17 claims
- 0493US9012462B2Phosphorous derivatives as kinase inhibitorsWANG YIHAN·Filed 2009·Granted Apr 21, 2015·28 cites·72 claims
- 0592US10227342B2Heteroaryl compounds for kinase inhibitionARIAD PHARMA INC·Filed 2015·Granted Mar 12, 2019·7 cites·14 claims
- 0691US9796712B2Heteroaryl compounds for kinase inhibitionARIAD PHARMA INC·Filed 2017·Granted Oct 24, 2017·6 cites·15 claims
- 0791US9278971B2Substituted acetylenic pyrazolo[1,5-a]pyrimidines as kinase inhibitorsARIAD PHARMA INC·Filed 2014·Granted Mar 8, 2016·10 cites·11 claims
- 0891US8778942B2Substituted acetylenic imidazo[1,2-A]pyrazine compounds as kinase inhibitorsARIAD PHARMA INC·Filed 2013·Granted Jul 15, 2014·11 cites·19 claims
- 0991US8470851B2Substituted acetylenic imidazo[1,2-A]pyridine compounds as kinase inhibitorsZOU Dong·Filed 2012·Granted Jun 25, 2013·13 cites·28 claims
- 1091US8278307B2Monocyclic Heteroaryl compoundsSHAKESPEARE WILLIAM C·Filed 2007·Granted Oct 2, 2012·21 cites·28 claims
- 1191US8071609B2Unsaturated heterocyclic derivativesWANG YIHAN·Filed 2006·Granted Dec 6, 2011·20 cites·17 claims
- 1291US6420384B2Proton pump inhibitorsARIAD PHARMA INC·Filed 2000·Granted Jul 16, 2002·32 cites·9 claims
- 1389US8461167B2Acetylenic heteroaryl compoundsWANG YIHAN·Filed 2007·Granted Jun 11, 2013·14 cites·17 claims
- 1487US8586566B2Unsaturated heterocyclic derivativesWANG YIHAN·Filed 2011·Granted Nov 19, 2013·11 cites·19 claims
- 1586US9090561B2Acetylenic heteroaryl compoundsWANG YIHAN·Filed 2012·Granted Jul 28, 2015·9 cites·24 claims
- 1685US9834571B2Compounds for inhibiting cell proliferation in EGFR-driven cancersARIAD PHARMA INC·Filed 2016·Granted Dec 5, 2017·2 cites·16 claims
- 1784US9834521B2Choline kinase inhibitorsARIAD PHARMA INC·Filed 2014·Granted Dec 5, 2017·4 cites·1 claims
- 1880US2022081440A1Substituted acetylenic pyrazolo[1,5-a]pyridine compounds as kinase inhibitorsARIAD PHARMA INC·Filed 2021·Application pending·0 cites
- 1978US2025361232A1Substituted acetylenic pyrazolo[1,5-a]pyridine compounds as kinase inhibitorsTAKEDA PHARMACEUTICALS USA INC·Filed 2025·Application pending·0 cites
- 2077US11001580B2Aminothiazole compounds as c-Kit inhibitorsARIAD PHARMA INC·Filed 2017·Granted May 11, 2021·1 cites·14 claims
- 2177US2024208960A1Aminothiazole compounds as c-kit inhibitorsARIAD PHARMA INC·Filed 2023·Application pending·0 cites
- 2276US11117883B2Benzimidazole compounds as c-Kit inhibitorsARIAD PHARMA INC·Filed 2017·Granted Sep 14, 2021·1 cites·7 claims
- 2375US11958850B2Heteroaryl compounds for kinase inhibitionTAKEDA PHARMACEUTICALS CO·Filed 2021·Granted Apr 16, 2024·0 cites·22 claims
- 2475US8912330B2Azaindole derivatives as kinase inhibitorsQI JIWEI·Filed 2009·Granted Dec 16, 2014·4 cites·28 claims
- 2575US2020231588A1Bicyclic Heteroaryl CompoundsARIAD PHARMA INC·Filed 2019·Application pending·0 cites
- 2673US2020317705A1Phosphorous derivatives as kinase inhibitorsARIAD PHARMA INC·Filed 2019·Application pending·0 cites
- 2771US11753404B2Aminothiazole compounds as c-Kit inhibitorsARIAD PHARMA INC·Filed 2021·Granted Sep 12, 2023·0 cites·4 claims
- 2869US7115589B2Purine derivativesARIAD PHARMA INC·Filed 2000·Granted Oct 3, 2006·4 cites·20 claims
- 2969US2019031656A1Substituted acetylenic pyrazolo[1,5-a]pyridine compounds as kinase inhibitorsARIAD PHARMA INC·Filed 2018·Application pending·0 cites
- 3066US9834518B2Compounds for inhibiting cell proliferation in EGFR-driven cancersDALGARNO DAVID C·Filed 2012·Granted Dec 5, 2017·2 cites·2 claims
- 3166US8496967B2Oral formulationsVLADYKA JR RONALD S·Filed 2009·Granted Jul 30, 2013·1 cites·18 claims
- 3266US2024150375A1Macrocyclic compounds and uses thereofTHESEUS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 3365US2019218212A1Heteroaryl compounds for kinase inhibitionARIAD PHARMA INC·Filed 2019·Application pending·0 cites
- 3464US2022064144A1Benzimidazole compounds as c-kit inhibitorsARIAD PHARMA INC·Filed 2021·Application pending·0 cites
- 3564US2020048288A1Phosphorous derivatives as kinase inhibitorsARIAD PHARMA INC·Filed 2019·Application pending·0 cites
- 3662US2016368917A1Bicyclic Heteroaryl CompoundsARIAD PHARMA INC·Filed 2016·Application pending·0 cites
- 3759US2017218000A1Phosphorous derivatives as kinase inhibitorsARIAD PHARMA INC·Filed 2017·Application pending·0 cites
- 3859US2024317731A1Aminothiazole compounds as c-kit inhibitorsTHESEUS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3959US2024199614A1Macrocyclic egfr inhibitors for the treatment of cancerTHESEUS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 4056US2008161335A1Oral formulationsVLADYKA RONALD S·Filed 2007·Application pending·0 cites
- 4156US2015166591A1Methods and compositions for raf kinase mediated diseasesARIAD PHARMA INC·Filed 2013·Application pending·0 cites
- 4254US2017369446A1Monocyclic heteroaryl compoundsARIAD PHARMA INC·Filed 2017·Application pending·0 cites
- 4354US2023148005A1Macrocyclic compounds and uses thereofTHESEUS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4454US2013005738A1Monocyclic Heteroaryl CompoundsARIAD PHARMA INC·Filed 2012·Application pending·0 cites
- 4552US2016376297A1Phosphorous Derivatives as Kinase InhibitorsARIAD PHARMA INC·Filed 2016·Application pending·0 cites
- 4652US2015225436A1Phosphorous derivatives as kinase inhibitorsARIAD PHARMA INC·Filed 2015·Application pending·0 cites
- 4751US2005096298A1Novel perinesFiled 2004·Application pending·0 cites
- 4847US2005065171A1Substituted purine derivativesFiled 2004·Application pending·0 cites
- 4942US2013225528A1Phosphorus Derivatives as Kinase InhibitorsARIAD PHARMA INC·Filed 2013·Application pending·0 cites
- 5042US2013225527A1Phosphorus Derivatives as Kinase InhibitorsARIAD PHARMA INC·Filed 2013·Application pending·0 cites
Showing the top 50 of 54 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when David C. Dalgarno files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →